PHAXIAM Therapeutics S.A. (PHXM.PA)

EUR 1.73

(-0.57%)

Total Assets Summary of PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.'s latest annual total assets in 2023 was 51.3 Million EUR , up 12.0% from previous year.
PHAXIAM Therapeutics S.A.'s latest quarterly total assets in 2024 Q2 was 39.11 Million EUR , down 0.0% from previous quarter.
PHAXIAM Therapeutics S.A. reported annual total assets of 45.81 Million EUR in 2022, down -31.39% from previous year.
PHAXIAM Therapeutics S.A. reported annual total assets of 66.76 Million EUR in 2021, down -16.96% from previous year.
PHAXIAM Therapeutics S.A. reported quarterly total assets of 39.11 Million EUR for 2024 Q2, down 0.0% from previous quarter.
PHAXIAM Therapeutics S.A. reported quarterly total assets of 51.3 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of PHAXIAM Therapeutics S.A. (2023 - 2016)

Historical Annual Total Assets of PHAXIAM Therapeutics S.A. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	51.3 Million EUR	12.0%
2022	45.81 Million EUR	-31.39%
2021	66.76 Million EUR	-16.96%
2020	80.4 Million EUR	-32.18%
2019	118.54 Million EUR	-29.37%
2018	167.84 Million EUR	-14.04%
2017	195.26 Million EUR	334.23%
2016	44.96 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	- EUR	-100.0%
2024 Q2	39.11 Million EUR	0.0%
2023 Q4	51.3 Million EUR	0.0%
2023 Q3	- EUR	-100.0%
2023 Q2	65.53 Million EUR	0.0%
2023 FY	51.3 Million EUR	12.0%
2023 Q1	65.53 Million EUR	43.05%
2022 Q2	65.98 Million EUR	0.0%
2022 Q3	- EUR	-100.0%
2022 Q4	45.81 Million EUR	0.0%
2021 Q2	83.8 Million EUR	0.0%
2021 Q4	66.76 Million EUR	0.0%
2020 Q4	80.4 Million EUR	0.0%
2020 Q2	89.1 Million EUR	0.0%
2019 Q4	118.54 Million EUR	0.0%

Peer Total Assets Comparison of PHAXIAM Therapeutics S.A.

Name	Total Assets	Total Assets Difference
Nicox S.A.	52.98 Million EUR	3.158%
European Medical Solutions	43.75 Million EUR	-17.252%
FERMENTALG	50.24 Million EUR	-2.116%